Home SRI International Announces PDCellX Xenograft Tumor Model Services To Accelerate Cancer Drug Research
 

Keywords :   


SRI International Announces PDCellX Xenograft Tumor Model Services To Accelerate Cancer Drug Research

2014-04-30 07:22:26| drugdiscoveryonline News Articles

SRI International has announced the availability of its PDCellX™ xenograft tumor model services for testing the activity of potential cancer therapeutics

Tags: services international research model

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
22.09Atlantic Tropical Weather Outlook
22.09Eastern North Pacific Tropical Weather Outlook
22.09Amazon says workers must be in the office. The UK government disagrees. Who is right?
22.09Eastern North Pacific Tropical Weather Outlook
22.09Atlantic Tropical Weather Outlook
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
21.09Strategies to minimize fallback pigs in the nursery
More »